Home › Attention Deficit Hyperactivity Disorder › Georgia
Attention Deficit Hyperactivity Disorder clinical trials in Georgia
4 studies for Attention Deficit Hyperactivity Disorder are looking for participants at sites in Georgia.
Cities in Georgia
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
- Advanced Discovery Research LLC, Atlanta
- Clinical Integrative Research Center of Atlanta, Atlanta
- CenExcel iResearch, LLC, Decatur
- and 1 more
RecruitingPhase 4
48 Months – 69 Months · All sexes · Updated Sep 11, 2026 · NCT04781140Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
- Clinical Research Site, Atlanta
RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Sep 8, 2026 · NCT07717892Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
- Clinical Research Site, Atlanta
RecruitingPhase 3
Ages 6 to 11 · All sexes · Updated Sep 8, 2026 · NCT07717879The Myelin Disorders Biorepository Project
- Emory University (Children's Healthcare of Atlanta), Atlanta
RecruitingObservational study
All ages · All sexes · Updated Oct 23, 2025 · NCT03047369From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.